Background illustration for clinical trials search

Paid Clinical Trials Atlanta

Discover 1,670 paid clinical trials in Atlanta, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

for
Ewing Sarcoma, Colorectal Adenocarcinoma
Location: Atlanta GA, Nashville TN, Cincinnati OH,
Sponsor: Inhibrx Biosciences, Inc

Sex: All

Age: 12 - 70+

Code: NCT03715933

Phase 1, Recruiting

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

for
Multiple Myeloma
Location: Atlanta GA, Winston-Salem NC, Chapel Hill NC,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05137054

Phase 1, Recruiting

Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma

for
Relapsed Multiple Myeloma, Refractory Multiple Myeloma
Location: Atlanta GA, Chapel Hill NC, Detroit MI, Grand Rapids MI,
Sponsor: Opna Bio LLC

Sex: All

Age: 18+

Code: NCT06433947

Phase 1, Recruiting

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung
Location: Atlanta GA, Athens GA, Chattanooga TN, Huntsville AL,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06890598

Phase 3, Recruiting

A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

for
Advanced Breast Cancer
Location: Atlanta GA, Nashville TN, Germantown TN,
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06638307

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL

for
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia,
Location: Atlanta GA, New York NY
Sponsor: Meryx, Inc.

Sex: All

Age: 12+

Code: NCT04872478

Phase 1, Recruiting

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

for
Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive
Location: Atlanta GA, Nashville TN, Charlotte NC, Durham NC,
Sponsor: Nuvalent Inc.

Sex: All

Age: 18+

Code: NCT06765109

Phase 3, Recruiting

Belantamab Mafodotin, Pomalidomide and Dexamethasone for the Treatment of High-Risk Myeloma

for
Plasma Cell Myeloma
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT05208307

Phase 2, Recruiting

A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

for
Hematological Malignancies
Location: Atlanta GA, Birmingham AL, Louisville KY,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT04634552

Phase 2, Recruiting

Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial

for
Low Grade Glioma, Malignant Brain Glioma,
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT06132685

Phase 2, Recruiting

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

for
Adult Acute Myeloid Leukemia
Location: Atlanta GA, Cincinnati OH, Tampa FL, Cleveland OH,
Sponsor: Priothera SAS

Sex: All

Age: 18 - 70+

Code: NCT05429632

Phase 3, Recruiting

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

for
Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma,
Location: Atlanta GA, Seneca SC, Easley SC, Greenville SC,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05633615

Phase 2, Recruiting

Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas

for
Salivary Gland Cancer, HER2 Gene Mutation
Location: Atlanta GA, Chicago IL, Basking Ridge NJ, Middletown NJ,
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT04620187

Phase 2, Recruiting

Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer

for
Stage III Prostate Cancer AJCC v8,
Location: Atlanta GA
Sponsor: Emory University

Sex: Male

Age: 18+

Code: NCT04725903

Recruiting

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

for
Locally Advanced Breast Cancer, Unresectable Breast Carcinoma,
Location: Atlanta GA, Athens GA, Nashville TN, St Louis MO,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT06827236

Phase 1, Phase 2, Recruiting

Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In

for
NSCLC Stage IV
Location: Atlanta GA, Nashville TN, Hickory NC, Charleston SC,
Sponsor: ImmunityBio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06745908

Phase 3, Recruiting

Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia

for
Severe Aplastic Anemia
Location: Atlanta GA, Birmingham AL, Nashville TN, Charlotte NC,
Sponsor: Medical College of Wisconsin

Sex: All

Age: 3 - 70+

Code: NCT06517641

Phase 2, Recruiting

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

for
Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm,
Location: Atlanta GA, Jacksonville FL, Wilson NC, Orlando FL,
Sponsor: BriaCell Therapeutics Corporation

Sex: All

Age: 18+

Code: NCT06072612

Phase 3, Recruiting

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis
Location: Atlanta GA, Athens GA, Chattanooga TN, Greenville SC,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06119581

Phase 3, Recruiting

A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer

for
Nasopharyngeal Cancer Recurrent
Location: Atlanta GA, Cincinnati OH, Little Rock AR, Cleveland OH,
Sponsor: Coherus Oncology, Inc.

Sex: All

Age: 12+

Code: NCT06457503

Recruiting